Discovery & Candidate Generation
- Client consultation
- Antigen design & production
- Immunization
- Single B-cell isolation & screening
The antibody you need is not always ready-made. Custom antibody programs can be challenging when target biology is complex, the optimal epitope is unclear or inaccessible, or screening does not yield antibodies suited to the intended application.
Our technical team works with you to create a development plan with clear timelines and project milestones. In-house antigen design capabilities support the project from the beginning, while the development approach is adapted around your assay and performance requirements.
Build recombinant rabbit monoclonal antibody candidates around your target biology, epitope requirements, and assay goals. From antigen design through clone selection and scale-up, you receive a milestone-based program with multiple candidates to evaluate and a path to reliable ongoing supply.
Selecting the right antigen design strategy early can help reduce project risk, limit rework, and improve downstream success. Through our collaboration with Precision BioTools, we offer EPISOLVE™ and EPIVOLVE® targeted epitope design options alongside sequence-defined antigen design.
These options provide flexibility to align the development approach with your target biology and discovery goal.
| Antigen Design Options | Supports | De-risking Benefit |
|---|---|---|
| EPISOLVE™ / EPIVOLVE® targeted epitope design | Functional specificity, including PTM recognition, and reduced cross-reactivity | Increases the likelihood of obtaining fit-for-purpose antibodies from the start |
| Sequence-defined antigen design | Early discovery and candidate diversity | Avoids early commitment to the wrong epitope and preserves discovery flexibility |
Starting with your protein target, we design an immunization strategy using in-house generated antigens, so the project is aligned to your needs from the beginning.
You then evaluate multiple candidate clones, allowing final selection to be based on measured performance rather than assumptions. From antigen design to clone selection, our approach is built to reduce uncertainty and support antibody programs that perform as intended.
A milestone-based development plan keeps your antibody project transparent, collaborative, and aligned to your application from the start.
We develop custom monoclonal antibodies across a range of target classes, including membrane proteins, secreted proteins, intracellular proteins, post-translational modifications, anti-idiotype targets, and small molecules.
Our monoclonal antibody generation platform delivers diverse clone sets to support customer-driven fit-for-purpose selection. We develop antibodies with your downstream application needs in mind, including assay performance and matched antibody pair requirements.
“We’ve been consistently pleased by Fortis’s initial candidate success rate. We’re now engaged in multiple projects with Fortis, with several anti-PTM clones about to be launched as formal genomic mapping reagents.”
Chief Scientific Officer
EpiCypher Inc.
“Some companies only splenectomize and proceed with one rabbit, whereas Fortis immunizes multiple rabbits, and these are all screened for antibodies to provide a distribution of the best potential candidates. In this way, we receive multiple options for performing our own screens.”
Project Manager
Valted Seq
“The whole process has been very easy, because Fortis cloned each B cell, enabling it to produce more antibodies and generate high yields.”
Head of Antibody Technology
NextPoint Therapeutics